Compass Wealth Management’s Amgen AMGN Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2025
Q4
Sell
-775
Closed -$219K 79
2025
Q3
$219K Hold
775
0.05% 145
2025
Q2
$216K Sell
775
-49
-6% -$13.9K 0.05% 147
2025
Q1
$257K Hold
824
0.07% 136
2024
Q4
$215K Hold
824
0.05% 148
2024
Q3
$266K Hold
824
0.06% 145
2024
Q2
$257K Hold
824
0.06% 142
2024
Q1
$234K Hold
824
0.06% 149
2023
Q4
$237K Hold
824
0.07% 144
2023
Q3
$221K Hold
824
0.07% 149
2023
Q2
$183K Hold
824
0.06% 156
2023
Q1
$199K Hold
824
0.06% 155
2022
Q4
$216K Buy
+824
New +$221K 0.07% 150

Other funds holding AMGN

Compass Wealth Management's AMGN Position: Q4 2025 in Review

Compass Wealth Management sold out of Amgen (AMGN) in Q4 2025, closing a stake of 775 shares — an estimated $219K sold.

Compass Wealth Management first reported a position in AMGN in Q4 2022 and held it in 12 quarters. The position peaked at $266K in Q3 2024. 3,084 funds tracked by Wall St. Rank hold AMGN as of Q4 2025.

  • Compass Wealth Management reported no remaining Amgen position as of Q4 2025 after selling out during the quarter.
  • Compass Wealth Management sold 775 Amgen shares in Q4 2025, an estimated $219K.
  • Compass Wealth Management first reported a position in Amgen in Q4 2022 and held it in 12 quarters.
  • Compass Wealth Management's Amgen position peaked at $266K in Q3 2024.
  • 3,084 funds tracked by Wall St. Rank held Amgen as of Q4 2025.

Based on Compass Wealth Management's 13F filing for Q4 2025, filed 11 Feb 2026.